Skip to Content

Newsroom

Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them.

 

Media Contact:

media.relations@endo.com
484-216-6829

Receive E-mail Alerts

You may automatically receive Endo news and financial information by email. To choose your options for email notification, please enter your email address below and click Submit. To change your email options at any time, re-enter your email address and click Submit, then adjust your form entries.

Subscribe